CytoDyn to Hold Webcast and Live Q/A on December 14

NEXT STORY
Roche presents pivotal data at ASH 2021 for novel cancer immunotherapy mosunetuzumab
PREV STORY
Merus présente une analyse actualisée du zenocutuzumab, du trastuzumab et de la vinorelbine chez des patientes atteintes d’un cancer du sein métastatique HER2+ lors du Symposium sur le cancer du sein de San Antonio
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Reata Announces Positive Results From Year 2 of the Pivotal Phase 3 CARDINAL Study of Bardoxolone Methyl in Patients with Alport Syndrome

author_avatar
NASDAQ Market News

Amgen, Cytokinetics and Servier Announce Start of METEORIC-HF, the Second Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients With Heart Failure

author_avatar
NASDAQ Market News

Ascendis Pharma A/S Announces Second Quarter 2021 Financial Results and Business Update Conference Call on August 25

author_avatar
NASDAQ Market News